Abstract
PD-1 is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 family. B7-H1 (PD-L1) and B7-DC (PD-L2), which belong to the B7 family, have been identified as ligands for PD-1. Paradoxically, it has been reported that both B7-H1 and B7-DC co-stimulate or inhibit T cell proliferation and cytokine production. To determine the role of B7-H1 and B7-DC in T cell-APC interactions, we examined the contribution of B7-H1 and B7-DC to CD4+ T cell activation by B cells, dendritic cells, and macrophages using anti-B7-H1, anti-B7-DC, and anti-PD-1 blocking mAbs. Anti-B7-H1 mAb and its Fab markedly inhibited the proliferation of anti-CD3-stimulated naive CD4+ T cells, but enhanced IL-2 and IFN-gamma production in the presence of macrophages. The inhibition of T cell proliferation by anti-B7-H1 mAb was abolished by neutralizing anti-IFN-gamma mAb. Coculture of CD4+ T cells and macrophages from IFN-gamma-deficient or wild-type mice showed that CD4+ T cell-derived IFN-gamma was mainly responsible for the inhibition of CD4+ T cell proliferation. Anti-B7-H1 mAb induced IFN-gamma-mediated production of NO by macrophages, and inducible NO synthase inhibitors abrogated the inhibition of CD4+ T cell proliferation by anti-B7-H1 mAb. These results indicated that the inhibition of T cell proliferation by anti-B7-H1 mAb was due to enhanced IFN-gamma production, which augmented NO production by macrophages, suggesting a critical role for B7-H1 on macrophages in regulating IFN-gamma production by naive CD4+ T cells and, hence, NO production by macrophages.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Blocking / pharmacology
-
B-Lymphocytes / immunology
-
B-Lymphocytes / metabolism
-
B7-1 Antigen / immunology
-
B7-1 Antigen / physiology
-
B7-H1 Antigen
-
CD4-Positive T-Lymphocytes / cytology
-
CD4-Positive T-Lymphocytes / drug effects
-
CD4-Positive T-Lymphocytes / immunology*
-
CD4-Positive T-Lymphocytes / metabolism
-
Cell Line
-
Cell Proliferation* / drug effects
-
Cricetinae
-
Dendritic Cells / immunology*
-
Dendritic Cells / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Growth Inhibitors / deficiency
-
Growth Inhibitors / genetics
-
Growth Inhibitors / physiology
-
Interferon-gamma / deficiency
-
Interferon-gamma / genetics
-
Interferon-gamma / physiology*
-
Lymphocyte Activation / immunology
-
Macrophages, Peritoneal / immunology*
-
Macrophages, Peritoneal / metabolism
-
Male
-
Membrane Glycoproteins / antagonists & inhibitors*
-
Membrane Glycoproteins / immunology
-
Membrane Glycoproteins / physiology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Nitric Oxide / biosynthesis*
-
Nitric Oxide / physiology
-
Nitric Oxide Synthase / antagonists & inhibitors
-
Nitric Oxide Synthase Type II
-
Ornithine / analogs & derivatives
-
Ornithine / pharmacology
-
Peptides / antagonists & inhibitors*
-
Peptides / immunology
-
Peptides / physiology
-
Programmed Cell Death 1 Ligand 2 Protein
-
Tryptophan Oxygenase / antagonists & inhibitors
-
omega-N-Methylarginine / pharmacology
Substances
-
Antibodies, Blocking
-
B7-1 Antigen
-
B7-H1 Antigen
-
Cd274 protein, mouse
-
Enzyme Inhibitors
-
Growth Inhibitors
-
Membrane Glycoproteins
-
Pdcd1lg2 protein, mouse
-
Peptides
-
Programmed Cell Death 1 Ligand 2 Protein
-
omega-N-Methylarginine
-
Nitric Oxide
-
N(G)-iminoethylornithine
-
Interferon-gamma
-
Ornithine
-
Tryptophan Oxygenase
-
Nitric Oxide Synthase
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse